Effect of Education on Alzheimer’s Disease-Related Neuroimaging Biomarkers in Healthy Controls,and Participants with Mild Cognitive Impairment and Alzheimer’s Disease: A Cross-Sectional Study
Restricted accessResearch articleFirst published online April 24, 2018
Effect of Education on Alzheimer’s Disease-Related Neuroimaging Biomarkers in Healthy Controls,and Participants with Mild Cognitive Impairment and Alzheimer’s Disease: A Cross-Sectional Study
Cognitive reserve is the acquired capacity reflecting a functional brain adaptability/flexibility in the context of aging. Educational attainment is thought to be among the most important factors that contribute to cognitive reserve.
Objective:
The aim of this study is to investigate the relationships among duration of education and Alzheimer’s disease (AD) related neuroimaging biomarkers such as amyloid-β deposition, glucose metabolism, and brain volumes in each stage of AD.
Methods:
We reanalyzed a part of the datasets of the Alzheimer’s Disease Neuroimaging Initiative. Participants were between 55 and 90 years of age and diagnosed as one of the following: healthy controls (HC), mild cognitive impairment (MCI), or AD. Multiple regression analyses were conducted to examine the relationships among duration of education and amyloid-β deposition (n = 825), brain metabolism (n = 1,304), and brain volumes (n = 1,606) among three groups using data for 18F-Florbetapir (AV-45) imaging, fludeoxyglucose (FDG) positron emission tomography, and T1-weighted magnetic resonance imaging.
Results:
Duration of education had no correlations with amyloid-β deposition or brain metabolism in any groups. However, duration of education was positively associated with the total brain volume only in participants with MCI.
Conclusions:
Our findings suggest that education may exert a protective effect on total brain volume in the MCI stage but not in HC or AD. Thus, education may play an important role in preventing the onset of dementia through brain reserve in MCI.
HurdMD, MartorellP, DelavandeA, MullenKJ, LangaKM (2013) Monetary costs of dementia in the United States. N Engl J Med368, 1326–1334.
2.
El KadmiriN, SaidN, SlassiI, El MoutawakilB, NadifiS (2018) Biomarkers for Alzheimer disease: Classical and novel candidates’ review. Neuroscience370, 181–190.
SternY (2012) Cognitive reserve in ageing and Alzheimer’s disease. Lancet Neurol11, 1006–1012.
5.
MurrayAD, StaffRT, McNeilCJ, SalariradS, AhearnTS, MustafaN, WhalleyLJ (2011) The balance between cognitive reserve and brain imaging biomarkers of cerebrovascular and Alzheimer’s diseases. Brain134, 3687–3696.
6.
McDowellI, XiG, LindsayJ, TierneyM (2007) Mapping the connections between education and dementia. J Clin Exp Neuropsychol29, 127–141.
7.
PietschnigJ, PenkeL, WichertsJM, ZeilerM, VoracekM (2015) Meta-analysis of associations between human brain volume and intelligence differences: How strong are they and what do they mean?. Neurosci Biobehav Rev57, 411–432.
8.
Bartres-FazD, Arenaza-UrquijoEM (2011) Structural and functional imaging correlates of cognitive and brain reserve hypotheses in healthy and pathological aging. Brain Topogr24, 340–357.
9.
DuboisB, FeldmanHH, JacovaC, DekoskyST, Barberger-GateauP, CummingsJ, DelacourteA, GalaskoD, GauthierS, JichaG, MeguroK, O’BrienJ, PasquierF, RobertP, RossorM, SallowayS, SternY, VisserPJ, ScheltensP (2007) Research criteria for the diagnosis of Alzheimer’s disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol6, 734–746.
10.
FotenosAF, MintunMA, SnyderAZ, MorrisJC, BucknerRL (2008) Brain volume decline in aging: Evidence for a relation between socioeconomic status, preclinical Alzheimer disease, and reserve. Arch Neurol65, 113–120.
JansenWJ, OssenkoppeleR, KnolDL, TijmsBM, ScheltensP, VerheyFR, VisserPJ, AaltenP, AarslandD, AlcoleaD, AlexanderM, AlmdahlIS, ArnoldSE, BaldeirasI, BarthelH, van BerckelBN, BibeauK, BlennowK, BrooksDJ, van BuchemMA, CamusV, CavedoE, ChenK, ChetelatG, CohenAD, DrzezgaA, EngelborghsS, FaganAM, FladbyT, FleisherAS, van der FlierWM, FordL, ForsterS, ForteaJ, FoskettN, FrederiksenKS, Freund-LeviY, FrisoniGB, FroelichL, GabryelewiczT, GillKD, GkatzimaO, Gomez-TortosaE, GordonMF, GrimmerT, HampelH, HausnerL, HellwigS, HerukkaSK, HildebrandtH, IshiharaL, IvanoiuA, JagustWJ, JohannsenP, KandimallaR, KapakiE, Klimkowicz-MrowiecA, KlunkWE, KohlerS, KoglinN, KornhuberJ, KrambergerMG, Van LaereK, LandauSM, LeeDY, de LeonM, LisettiV, LleoA, MadsenK, MaierW, MarcussonJ, MattssonN, de MendoncaA, MeulenbroekO, MeyerPT, MintunMA, MokV, MolinuevoJL, MollergardHM, MorrisJC, MroczkoB, Van der MusseleS, NaDL, NewbergA, NordbergA, NordlundA, NovakGP, ParaskevasGP, ParnettiL, PereraG, PetersO, PoppJ, PrabhakarS, RabinoviciGD, RamakersIH, RamiL, Resende de OliveiraC, RinneJO, RodrigueKM, Rodriguez-RodriguezE, RoeCM, RotU, RoweCC, RutherE, SabriO, Sanchez-JuanP, SantanaI, SarazinM, SchroderJ, SchutteC, SeoSW, SoeteweyF, SoininenH, SpiruL, StruyfsH, TeunissenCE, TsolakiM, VandenbergheR, VerbeekMM, VillemagneVL, VosSJ, van Waalwijk van DoornLJ, WaldemarG, WallinA, WallinAK, WiltfangJ, WolkDA, ZbochM, ZetterbergH (2015) Prevalence of cerebral amyloid pathology in persons without dementia: A meta-analysis. JAMA313, 1924–1938.
13.
Serrano-PozoA, QianJ, MonsellSE, FroschMP, BetenskyRA, HymanBT (2013) Examination of the clinicopathologic continuum of Alzheimer disease in the autopsy cohort of the National Alzheimer Coordinating Center. J Neuropathol Exp Neurol72, 1182–1192.
14.
Arenaza-UrquijoEM, LandeauB, La JoieR, MevelK, MezengeF, PerrotinA, DesgrangesB, Bartres-FazD, EustacheF, ChetelatG (2013) Relationships between years of education and gray matter volume, metabolism and functional connectivity in healthy elders. Neuroimage83, 450–457.
15.
Arenaza-UrquijoEM, GonneaudJ, FouquetM, PerrotinA, MezengeF, LandeauB, EgretS, De la SayetteV, DesgrangesB, ChetelatG (2015) Interaction between years of education and APOE epsilon4 status on frontal and temporal metabolism. Neurology85, 1392–1399.
16.
CarapelleE, SerraL, ModoniS, FalconeM, CaltagironeC, BozzaliM, SpecchioLM, AvolioC (2017) How the cognitive reserve interacts with beta-amyloid deposition in mitigating FDG metabolism: An observational study. Medicine (Baltimore)96, e5876.
BickelH, CooperB (1994) Incidence and relative risk of dementia in an urban elderly population: Findings of a prospective field study. Psychol Med24, 179–192.
19.
SchaieKW (1993) The Seattle Longitudinal Study: A thirty-five-year inquiry of adult intellectual development. Z Gerontol26, 129–137.
20.
AchariyarTM, LiB, PengW, VerghesePB, ShiY, McConnellE, BenraissA, KasperT, SongW, TakanaT, HoltzmanDM, NedergaardM, DeaneR (2016) Glymphatic distribution of CSF-derived apoE into brain is isoform specific and suppressed during sleep deprivation. Mol Neurodegener11, 74.
21.
ScarmeasN, LuchsingerJA, SchupfN, BrickmanAM, CosentinoS, TangMX, SternY (2009) Physical activity, diet, and risk of Alzheimer disease. JAMA302, 627–637.
Singh-ManouxA, DugravotA, FournierA, AbellJ, EbmeierK, KivimakiM, SabiaS (2017) Trajectories of depressive symptoms before diagnosis of dementia: A 28-year follow-up study. JAMA Psychiatry74, 712–718.
25.
AndrewsSJ, EramudugollaR, VelezJI, CherbuinN, EastealS, AnsteyKJ (2017) Validating the role of the Australian National University Alzheimer’s Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years. Alzheimers Res Ther9, 16.
